Reassessing COVID-19 Vaccine Safety: A Five-Year Analysis of VAERS Reports on Harms and Mortality

John Murphy, The COVID Long-haul Foundation Abstract This article presents a comprehensive analysis of adverse event reports submitted to the Vaccine Adverse Event Reporting System (VAERS) from December 2020 through…[...]

Read More

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease

Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730  PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In…[...]

Read More

Unmasking the Long-Term Effects of COVID-19 With a Focus on Chronic Fatigue Syndrome: A Community-Based Study From India

Arti Gupta • Vishnu Rajan • Rajeev Aravindakshan • Pulla Sirisha, DOI: 10.7759/cureus.80597  Abstract Background The COVID-19 pandemic has highlighted the enduring health burden of long COVID, scientifically termed the postacute sequelae of severe acute respiratory syndrome…[...]

Read More